SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery
RecruitingNot applicableNCT07436806
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to evaluate the efficacy of ultrasound-guided Serratus Posterior Superior (SPS) block compared to surgeon-administered intercostal blockade in preventing chronic pain at 3, 6, and 12 months following Video-Assisted Thoracoscopic Surgery (VATS).
Study details
- Official title
- Evaluation of Serratus Posterior Superior (SPS) Block Versus Surgical Intercostal Blockade in Preventing Chronic Post-Thoracotomy Pain After Video-Assisted Thoracoscopic Surgery (VATS): A Randomized, Prospective, Comparative Study.
- Conditions
- Chronic Post-thoracotomy Pain
- Neuropathic Pain
- Postoperative Pain, Acute
- Interventions
- Drug: SPS block
- Drug: Surgical Intercostal Blockade.
- Sponsor
- Medipol University
- Start date
- 2026-03-01
- Primary completion
- 2026-11-20
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ASA physical status I-III. * Scheduled for elective unilateral Video-Assisted Thoracoscopic Surgery (VATS). Exclusion Criteria: * History of allergy to local anesthetics. * Pre-existing chronic pain syndrome or neuropathic pain. * Psychiatric disorders affecting pain assessment. * Coagulation disorders. * Previous thoracic surgery on the same side.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07436806